Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD.

Author(s): Saccone NL,  Culverhouse RC,  Schwantes-An TH,  Cannon DS,  Chen X,  Cichon S,  Giegling I,  Han S,  Han Y,  Keskitalo-Vuokko K,  Kong X,  Landi MT,  Ma JZ,  Short SE,  Stephens SH,  Stevens VL,  Sun L,  Wang Y,  Wenzlaff AS,  Aggen SH,  Breslau N,  Broderick P,  Chatterjee N,  Chen J,  Heath AC,  Heliövaara M,  Hoft NR,  Hunter DJ,  Jensen MK,  Martin NG,  Montgomery GW,  Niu T,  Payne TJ,  Peltonen L,  Pergadia ML,  Rice JP,  Sherva R,  Spitz MR,  Sun J,  Wang JC,  Weiss RB,  Wheeler W,  Witt SH,  Yang BZ,  Caporaso NE,  Ehringer MA,  Eisen T,  Gapstur SM,  Gelernter J,  Houlston R,  Kaprio J,  Kendler KS,  Kraft P,  Leppert MF,  Li MD,  Madden PA,  Nöthen MM,  Pillai S,  Rietschel M,  Rujescu D,  Schwartz A,  Amos CI,  Bierut LJ

Journal: PLoS Genet

Date: 2010 Aug 5

Major Program(s) or Research Group(s): PLCO

PubMed ID: 20700436

PMC ID: PMC2916847

Abstract: Recently, genetic association findings for nicotine dependence, smoking behavior, and smoking-related diseases converged to implicate the chromosome 15q25.1 region, which includes the CHRNA5-CHRNA3-CHRNB4 cholinergic nicotinic receptor subunit genes. In particular, association with the nonsynonymous CHRNA5 SNP rs16969968 and correlates has been replicated in several independent studies. Extensive genotyping of this region has suggested additional statistically distinct signals for nicotine dependence, tagged by rs578776 and rs588765. One goal of the Consortium for the Genetic Analysis of Smoking Phenotypes (CGASP) is to elucidate the associations among these markers and dichotomous smoking quantity (heavy versus light smoking), lung cancer, and chronic obstructive pulmonary disease (COPD). We performed a meta-analysis across 34 datasets of European-ancestry subjects, including 38,617 smokers who were assessed for cigarettes-per-day, 7,700 lung cancer cases and 5,914 lung-cancer-free controls (all smokers), and 2,614 COPD cases and 3,568 COPD-free controls (all smokers). We demonstrate statistically independent associations of rs16969968 and rs588765 with smoking (mutually adjusted p-values<10(-35) and <10(-8) respectively). Because the risk alleles at these loci are negatively correlated, their association with smoking is stronger in the joint model than when each SNP is analyzed alone. Rs578776 also demonstrates association with smoking after adjustment for rs16969968 (p<10(-6)). In models adjusting for cigarettes-per-day, we confirm the association between rs16969968 and lung cancer (p<10(-20)) and observe a nominally significant association with COPD (p = 0.01); the other loci are not significantly associated with either lung cancer or COPD after adjusting for rs16969968. This study provides strong evidence that multiple statistically distinct loci in this region affect smoking behavior. This study is also the first report of association between rs588765 (and correlates) and smoking that achieves genome-wide significance; these SNPs have previously been associated with mRNA levels of CHRNA5 in brain and lung tissue.